These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 5335103)
1. The prevention of drug-induced retinopathies. Crews SJ Trans Ophthalmol Soc U K (1962); 1966; 86():63-76. PubMed ID: 5335103 [No Abstract] [Full Text] [Related]
2. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies. Alfieri R; Sole P Ophthalmologica; 1969; 158 Suppl():661-8. PubMed ID: 5359763 [No Abstract] [Full Text] [Related]
4. [Ocular involvement in chloroquine therapy]. Godel V; Nemet P; Stein R Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910 [No Abstract] [Full Text] [Related]
5. Chloroquine and organic changes in the eye. Carr RE Dis Nerv Syst; 1968 Mar; 29(3):Suppl:36-9. PubMed ID: 5672562 [No Abstract] [Full Text] [Related]
6. Ocular toxicity of antimalarial drugs. Long-term follow-up. Carr RE; Henkind P; Rothfield N; Siegel IM Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592 [No Abstract] [Full Text] [Related]
8. Electrodiagnosis in drug-induced disorders of the eye. Adlakha D; Crews SJ; Shearer AC; Tonks EL Trans Ophthalmol Soc U K (1962); 1967; 87():267-84. PubMed ID: 5255222 [No Abstract] [Full Text] [Related]
9. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average]. Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115 [No Abstract] [Full Text] [Related]
10. Drug-induced macular disease. Potts AM Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468 [No Abstract] [Full Text] [Related]
11. [On the problem of chloroquine damage to the eye]. Böke W; Bäumer A; Müller-Limmroth W; Mludek M Klin Monbl Augenheilkd; 1967 Nov; 151(5):617-33. PubMed ID: 5597423 [No Abstract] [Full Text] [Related]
12. Acquired color vision defects secondary to retinal drug toxicity. Grützner P Ophthalmologica; 1969; 158 Suppl():592-604. PubMed ID: 5307973 [No Abstract] [Full Text] [Related]
13. [Routine monitoring of patients treated with synthetic antimalarials]. Douche C; Bechetoille A; Ebran JM J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659 [TBL] [Abstract][Full Text] [Related]
14. [Eye disorders caused by chloroquine and hydroxychloroquine]. Pinckers A Ned Tijdschr Geneeskd; 1970 Apr; 114(15):631-6. PubMed ID: 5445130 [No Abstract] [Full Text] [Related]
15. The ocular toxicity of chloroquine. Percival SP Trans Ophthalmol Soc U K (1962); 1967; 87():355-7. PubMed ID: 5255230 [No Abstract] [Full Text] [Related]
16. [The changes in the electric retinal activity during resochin treatment]. Svĕrák J; Peregrin J; Salavec M Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424 [No Abstract] [Full Text] [Related]
18. Evaluation of several tests in screening for chloroquine maculopathy. Bishara SA; Matamoros N Eye (Lond); 1989; 3 ( Pt 6)():777-82. PubMed ID: 2630362 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic observation of chloroquine retinopathy]. Kikkawa T Ganka; 1971 Jul; 13(7):726-36. PubMed ID: 5105836 [No Abstract] [Full Text] [Related]
20. Blue-yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy. Razeghinejad MR; Torkaman F; Amini H Med Hypotheses; 2005; 65(3):629-30. PubMed ID: 15949899 [No Abstract] [Full Text] [Related] [Next] [New Search]